Invitrogen™ mirVana™ miRNA Inhibitor, Negative Control #1

Description

mirVana miRNA Inhibitor Negative Control No. 1 is a non-targeting control designed for use in miRNA inhibition experiments. It provides a reliable baseline for evaluating the effects on target gene expression by ensuring minimal off-target effects. Extensively tested in human cell lines and tissues, this control is validated to have no impact on known miRNA functions, making it essential for accurate and consistent gene expression studies. Its properties include high reliability, superior specificity, and versatile use in various experimental setups.

Features of mirVana miRNA Inhibitor Negative Control No. 1 include:

• Reliability—maximum and consistent effect in vitro at low concentration and low toxicity
• Potency—better potency than lead competitor's product
• Superior specificity—the most updated Sanger content
• Versatile use—can be used in vitro and in vivo, offering you consistency throughout your entire research project

What are mirVana miRNA Inhibitors?

mirVana miRNA inhibitors are small, chemically modified single-stranded RNA molecules designed to specifically bind to and inhibit endogenous miRNA molecules and enable miRNA functional analysis by down-regulation of miRNA activity. Positive and negative controls are also available for use along with mirVana miRNA inhibitors in miRNA down-regulation experiments.

Quality control

Each mirVana miRNA Inhibitor is synthesized and purified in state-of-the-art facilities to meet the highest quality standards. Our rigorous quality control procedures include MALDI-TOF mass spectrometry analysis and analytical HPLC to monitor purity. We also assess each miRNA Inhibitor by gel electrophoresis to ensure a premium-quality miRNA inhibitor that is purified and ready for use.